Mondrian Investment Partners LTD Takeda Pharmaceutical CO LTD Transaction History

Mondrian Investment Partners LTD

$6.01 Billion
Q3 2024

A detailed history of Mondrian Investment Partners LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 5,094,455 shares of TAK stock, worth $66.8 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

5,094,455

Previous 7,738,748 34.17%

Holding current value

$66.8 Million

Previous $100 Million 27.71%

% of portfolio

1.21%

Previous 1.74%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$13.0 - $15.08 $34.4 Million - $39.9 Million	-2,644,293 Reduced 34.17%	5,094,455 $72.4 Million
Q2 2024 Aug 12, 2024	SELL	$12.6 - $13.67 $54.7 Million - $59.3 Million	-4,341,214 Reduced 35.94%	7,738,748 $100 Million
Q1 2024 May 07, 2024	BUY	$13.89 - $15.04 $54.3 Million - $58.8 Million	3,912,569 Added 47.9%	12,079,962 $168 Million
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $54.6 Million - $63 Million	4,085,678 Added 100.1%	8,167,393 $117 Million
Q1 2023 May 09, 2023	SELL	$15.28 - $16.48 $4.37 Million - $4.71 Million	-286,000 Reduced 6.55%	4,081,715 $65.3 Million
Q4 2022 Feb 03, 2023	SELL	$12.42 - $15.62 $4.77 Million - $6 Million	-384,000 Reduced 8.08%	4,367,715 $69.9 Million
Q2 2022 Aug 09, 2022	BUY	$13.12 - $15.03 $5.67 Million - $6.49 Million	432,000 Added 10.0%	4,751,715 $66.5 Million
Q1 2022 May 05, 2022	BUY	$13.54 - $15.35 $3.53 Million - $4.01 Million	261,000 Added 6.43%	4,319,715 $60.5 Million
Q4 2021 Feb 09, 2022	BUY	$13.17 - $16.4 $4.68 Million - $5.83 Million	355,311 Added 9.59%	4,058,715 $56.8 Million
Q2 2021 Jul 30, 2021	BUY	$16.55 - $18.64 $3.19 Million - $3.6 Million	193,000 Added 5.5%	3,703,404 $63 Million
Q1 2021 May 10, 2021	BUY	$16.71 - $19.9 $3.94 Million - $4.69 Million	235,744 Added 7.2%	3,510,404 $59.7 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $3.47 Million - $4.27 Million	225,186 Added 7.38%	3,274,660 $58.9 Million
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $339,058 - $380,499	19,828 Added 0.65%	3,049,474 $45.7 Million
Q2 2020 Aug 10, 2020	SELL	$14.59 - $19.5 $5.83 Million - $7.79 Million	-399,524 Reduced 11.65%	3,029,646 $54.5 Million
Q1 2020 May 12, 2020	SELL	$13.02 - $20.31 $2.73 Million - $4.27 Million	-210,000 Reduced 5.77%	3,429,170 $51.4 Million
Q3 2019 Nov 04, 2019	BUY	$16.15 - $17.99 $3.7 Million - $4.12 Million	229,000 Added 6.72%	3,639,170 $61.9 Million
Q2 2019 Aug 07, 2019	BUY	$16.58 - $20.49 $6.59 Million - $8.14 Million	397,300 Added 13.19%	3,410,170 $61.4 Million
Q1 2019 Apr 17, 2019	BUY	$16.7 - $21.52 $2.32 Million - $2.99 Million	139,000 Added 4.84%	3,012,870 $60.3 Million
Q4 2018 Jan 24, 2019	BUY	$15.64 - $21.1 $44.9 Million - $60.6 Million	2,873,870 New	2,873,870 $48.9 Million

Others Institutions Holding TAK

# of Institutions

338

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.8B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mondrian Investment Partners LTD with notifications on news.

Account

Mondrian Investment Partners LTD Takeda Pharmaceutical CO LTD Transaction History